Stem definition | Drug id | CAS RN |
---|---|---|
838 | 81-13-0 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Feb. 20, 1953 | FDA | HOSPIRA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pneumonia aspiration | 146.52 | 11.45 | 128 | 25242 | 31477 | 46629215 |
Gastrooesophageal reflux disease | 120.83 | 11.45 | 174 | 25196 | 74170 | 46586522 |
Toxicity to various agents | 80.87 | 11.45 | 10 | 25360 | 211756 | 46448936 |
Coma | 76.98 | 11.45 | 124 | 25246 | 58225 | 46602467 |
Neuropathy peripheral | 69.59 | 11.45 | 153 | 25217 | 90740 | 46569952 |
Somnolence | 63.36 | 11.45 | 208 | 25162 | 156313 | 46504379 |
Fatigue | 60.88 | 11.45 | 549 | 24821 | 608148 | 46052544 |
Diarrhoea | 41.06 | 11.45 | 474 | 24896 | 559128 | 46101564 |
Full blood count decreased | 39.01 | 11.45 | 54 | 25316 | 22157 | 46638535 |
Muscle spasms | 34.96 | 11.45 | 146 | 25224 | 122967 | 46537725 |
Drug hypersensitivity | 28.39 | 11.45 | 56 | 25314 | 243769 | 46416923 |
Dry skin | 26.90 | 11.45 | 65 | 25305 | 40951 | 46619741 |
Off label use | 26.12 | 11.45 | 112 | 25258 | 379729 | 46280963 |
Drug ineffective | 24.58 | 11.45 | 243 | 25127 | 677595 | 45983097 |
Product compounding quality issue | 24.49 | 11.45 | 7 | 25363 | 138 | 46660554 |
Drug abuse | 24.15 | 11.45 | 3 | 25367 | 63405 | 46597287 |
Drug interaction | 22.48 | 11.45 | 48 | 25322 | 203046 | 46457646 |
Contraindicated product administered | 21.93 | 11.45 | 8 | 25362 | 79939 | 46580753 |
Product dose omission issue | 21.51 | 11.45 | 161 | 25209 | 168359 | 46492333 |
Synovitis | 20.74 | 11.45 | 4 | 25366 | 61071 | 46599621 |
Intentional overdose | 20.54 | 11.45 | 5 | 25365 | 64939 | 46595753 |
White blood cell count decreased | 20.28 | 11.45 | 117 | 25253 | 112114 | 46548578 |
Acute kidney injury | 19.12 | 11.45 | 65 | 25305 | 235790 | 46424902 |
Multiple sclerosis relapse | 18.84 | 11.45 | 58 | 25312 | 42067 | 46618625 |
Peripheral swelling | 18.49 | 11.45 | 148 | 25222 | 157923 | 46502769 |
Maternal condition affecting foetus | 18.33 | 11.45 | 6 | 25364 | 189 | 46660503 |
Balance disorder | 17.89 | 11.45 | 76 | 25294 | 64445 | 46596247 |
Suicide attempt | 17.87 | 11.45 | 4 | 25366 | 55032 | 46605660 |
Rheumatoid arthritis | 17.62 | 11.45 | 69 | 25301 | 240146 | 46420546 |
Diabetic foot | 17.48 | 11.45 | 11 | 25359 | 1639 | 46659053 |
Systemic lupus erythematosus | 17.09 | 11.45 | 7 | 25363 | 65173 | 46595519 |
Sleep apnoea syndrome | 16.54 | 11.45 | 37 | 25333 | 22164 | 46638528 |
Tooth disorder | 16.43 | 11.45 | 38 | 25332 | 23265 | 46637427 |
Exposure during pregnancy | 16.21 | 11.45 | 21 | 25349 | 108191 | 46552501 |
Hypoaesthesia | 15.98 | 11.45 | 115 | 25255 | 118754 | 46541938 |
Poor quality sleep | 15.62 | 11.45 | 29 | 25341 | 15224 | 46645468 |
Interstitial lung disease | 15.49 | 11.45 | 5 | 25365 | 53944 | 46606748 |
Fall | 15.15 | 11.45 | 257 | 25113 | 328840 | 46331852 |
Treatment failure | 15.07 | 11.45 | 17 | 25353 | 93070 | 46567622 |
Arrhythmia neonatal | 14.55 | 11.45 | 4 | 25366 | 68 | 46660624 |
Nasopharyngitis | 14.27 | 11.45 | 137 | 25233 | 153861 | 46506831 |
Skin abrasion | 13.96 | 11.45 | 20 | 25350 | 8468 | 46652224 |
Multiple lentigines syndrome | 13.38 | 11.45 | 5 | 25365 | 234 | 46660458 |
Optic nerve disorder | 13.37 | 11.45 | 7 | 25363 | 737 | 46659955 |
Seasonal allergy | 13.21 | 11.45 | 25 | 25345 | 13309 | 46647383 |
Nonalcoholic fatty liver disease | 12.98 | 11.45 | 7 | 25363 | 782 | 46659910 |
Chronic kidney disease-mineral and bone disorder | 12.79 | 11.45 | 5 | 25365 | 265 | 46660427 |
Sinus disorder | 12.79 | 11.45 | 28 | 25342 | 16535 | 46644157 |
Sinusitis | 12.30 | 11.45 | 116 | 25254 | 129652 | 46531040 |
Memory impairment | 12.29 | 11.45 | 78 | 25292 | 77259 | 46583433 |
Naevus flammeus | 12.22 | 11.45 | 4 | 25366 | 126 | 46660566 |
Rosacea | 12.18 | 11.45 | 12 | 25358 | 3429 | 46657263 |
Insomnia | 12.12 | 11.45 | 140 | 25230 | 164784 | 46495908 |
Gonorrhoea | 11.84 | 11.45 | 4 | 25366 | 139 | 46660553 |
Urine calcium/creatinine ratio increased | 11.79 | 11.45 | 4 | 25366 | 141 | 46660551 |
Rhinorrhoea | 11.59 | 11.45 | 54 | 25316 | 47611 | 46613081 |
Pre-existing condition improved | 11.49 | 11.45 | 16 | 25354 | 6596 | 46654096 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Neuropathy peripheral | 70.28 | 13.05 | 110 | 11579 | 70365 | 29870424 |
Fatigue | 50.23 | 13.05 | 252 | 11437 | 320421 | 29620368 |
Toxicity to various agents | 34.56 | 13.05 | 13 | 11676 | 177170 | 29763619 |
Full blood count decreased | 30.40 | 13.05 | 34 | 11655 | 15683 | 29925106 |
Cerebral haemorrhage neonatal | 26.46 | 13.05 | 8 | 11681 | 272 | 29940517 |
Multiple sclerosis relapse | 20.15 | 13.05 | 23 | 11666 | 10839 | 29929950 |
Relapsing-remitting multiple sclerosis | 18.60 | 13.05 | 6 | 11683 | 253 | 29940536 |
Dysuria | 18.14 | 13.05 | 32 | 11657 | 22509 | 29918280 |
Stiff person syndrome | 17.50 | 13.05 | 5 | 11684 | 139 | 29940650 |
Generalised oedema | 16.90 | 13.05 | 22 | 11667 | 11863 | 29928926 |
Rash | 16.72 | 13.05 | 130 | 11559 | 191759 | 29749030 |
Febrile bone marrow aplasia | 16.49 | 13.05 | 18 | 11671 | 8079 | 29932710 |
Plasma cell myeloma | 16.39 | 13.05 | 52 | 11637 | 53410 | 29887379 |
Dermatitis contact | 16.30 | 13.05 | 12 | 11677 | 3219 | 29937570 |
Constipation | 15.65 | 13.05 | 86 | 11603 | 112820 | 29827969 |
Insomnia | 14.94 | 13.05 | 74 | 11615 | 93262 | 29847527 |
Pseudopolyposis | 14.20 | 13.05 | 3 | 11686 | 22 | 29940767 |
Drug interaction | 14.18 | 13.05 | 36 | 11653 | 199532 | 29741257 |
Influenza | 14.03 | 13.05 | 43 | 11646 | 43355 | 29897434 |
Muscle spasms | 13.83 | 13.05 | 56 | 11633 | 64782 | 29876007 |
Sleep apnoea syndrome | 13.65 | 13.05 | 24 | 11665 | 16833 | 29923956 |
Balance disorder | 13.56 | 13.05 | 38 | 11651 | 36455 | 29904334 |
Product dose omission issue | 13.51 | 13.05 | 71 | 11618 | 91560 | 29849229 |
Back pain | 13.45 | 13.05 | 77 | 11612 | 102519 | 29838270 |
Peripheral swelling | 13.23 | 13.05 | 53 | 11636 | 61021 | 29879768 |
Pouchitis | 13.18 | 13.05 | 6 | 11683 | 651 | 29940138 |
Source | Code | Description |
---|---|---|
ATC | A11HA30 | ALIMENTARY TRACT AND METABOLISM VITAMINS OTHER PLAIN VITAMIN PREPARATIONS Other plain vitamin preparations |
ATC | D03AX03 | DERMATOLOGICALS PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS CICATRIZANTS Other cicatrizants |
ATC | S01XA12 | SENSORY ORGANS OPHTHALMOLOGICALS OTHER OPHTHALMOLOGICALS Other ophthalmologicals |
CHEBI has role | CHEBI:38323 | cholinergic drugs |
CHEBI has role | CHEBI:50188 | provitamins |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Eczema | indication | 43116000 | |
Toxicodendron radicans | indication | 52352005 | |
Paralytic ileus | indication | 55525008 | DOID:8442 |
Diaper rash | indication | 91487003 | |
Disorder of skin | indication | 95320005 | DOID:37 |
Contact dermatitis due to poison oak | indication | 200824008 | |
Gastroparesis | indication | 235675006 | |
Arthropod bite wound | indication | 409985002 | |
Paralytic Ileus Prevention | indication | ||
Chafing of skin | off-label use | 238474002 | |
Eruption of skin | off-label use | 271807003 | DOID:0050486 |
Skin irritation | off-label use | 367466007 | |
Itching of skin | off-label use | 418363000 | |
Hemophilia | contraindication | 90935002 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 12.71 | acidic |
None
None
None
ID | Source |
---|---|
4020828 | VUID |
N0000146036 | NUI |
4017657 | VANDF |
4020828 | VANDF |
C0057610 | UMLSCUI |
CHEBI:27373 | CHEBI |
CHEMBL1200979 | ChEMBL_ID |
131204 | PUBCHEM_CID |
DB09357 | DRUGBANK_ID |
C007288 | MESH_SUPPLEMENTAL_RECORD_UI |
1023 | INN_ID |
1O6C93RI7Z | UNII |
22701 | RXNORM |
1536 | MMSL |
4558 | MMSL |
d01001 | MMSL |
001696 | NDDF |
126226000 | SNOMEDCT_US |
404842009 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
B-PLEX 100 | HUMAN PRESCRIPTION DRUG LABEL | 5 | 30727-300 | INJECTION, SOLUTION | 2 mg | INTRAMUSCULAR | unapproved drug other | 10 sections |
HASOL Anagen Hair Tonic | HUMAN OTC DRUG LABEL | 3 | 51270-122 | LIQUID | 0.00 1 | TOPICAL | unapproved drug other | 8 sections |
HASOL Anagen Scalp | HUMAN OTC DRUG LABEL | 3 | 51270-123 | SHAMPOO | 0.00 1 | TOPICAL | unapproved drug other | 8 sections |
HASOL Anti Hair Loss | HUMAN OTC DRUG LABEL | 3 | 51270-124 | SHAMPOO | 0.00 1 | TOPICAL | unapproved drug other | 8 sections |
HASOL Vital For Hair-Loss Tonic | HUMAN OTC DRUG LABEL | 3 | 51270-125 | LIQUID | 0.00 1 | TOPICAL | unapproved drug other | 8 sections |
PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-5646 | INJECTION, SOLUTION | 5 mg | INTRAVENOUS | NDA | 19 sections |
Adult Infuvite Multiple Vitamins for Infusion | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-5649 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 17 sections |
Adult Infuvite Multiple Vitamins for Infusion | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-5649 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 17 sections |
Infuvite Adult Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-5650 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 20 sections |
Adult Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-7862 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 20 sections |
Adult Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-7874 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 20 sections |
Pediatric Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-7886 | INJECTION, SOLUTION | 5 mg | INTRAVENOUS | NDA | 19 sections |
Adult Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-9007 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 20 sections |
Adult Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-9015 | INJECTION, SOLUTION | 15 mg | INTRAVENOUS | NDA | 20 sections |
Pediatric Infuvite Multiple Vitamins | HUMAN PRESCRIPTION DRUG LABEL | 13 | 54643-9023 | INJECTION, SOLUTION | 5 mg | INTRAVENOUS | NDA | 19 sections |
M.V.I. Pediatric | HUMAN PRESCRIPTION DRUG LABEL | 13 | 61703-421 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 5 mg | INTRAVENOUS | NDA | 21 sections |
Vitamin B Complex | HUMAN PRESCRIPTION DRUG LABEL | 5 | 67457-146 | INJECTION | 2 mg | INTRAVENOUS | Unapproved drug other | 9 sections |
NDM SCALP | HUMAN OTC DRUG LABEL | 4 | 69288-001 | SHAMPOO | 1.40 g | TOPICAL | unapproved drug other | 11 sections |
YOZUM WELL BEING HAIR COLOR | HUMAN OTC DRUG LABEL | 1 | 69525-2001 | LIQUID | 0.20 g | TOPICAL | OTC monograph not final | 7 sections |
Notamo Hair Tonic | HUMAN OTC DRUG LABEL | 2 | 69709-102 | LIQUID | 0.20 1 | TOPICAL | unapproved drug other | 8 sections |
Vitamin B Complex | HUMAN PRESCRIPTION DRUG LABEL | 5 | 69877-026 | INJECTION, SOLUTION | 2 mg | INTRAMUSCULAR | unapproved drug other | 10 sections |
B-Combo | HUMAN PRESCRIPTION DRUG LABEL | 6 | 70104-110 | INJECTION | 1 mg | INTRAMUSCULAR | unapproved drug other | 1 sections |
Lipovite | HUMAN PRESCRIPTION DRUG LABEL | 13 | 70104-128 | INJECTION | 1 mg | INTRAMUSCULAR | unapproved drug other | 1 sections |
Therapytion Hair Tonic | HUMAN OTC DRUG LABEL | 2 | 70477-101 | LIQUID | 0.00 1 | TOPICAL | unapproved drug other | 8 sections |
VITAMIN B COMPLEX | HUMAN PRESCRIPTION DRUG LABEL | 5 | 71414-225 | INJECTION | 2 mg | INTRAVENOUS | unapproved drug other | 9 sections |
Pelo Scalp Tonic Sheet | HUMAN OTC DRUG LABEL | 3 | 73099-010 | PATCH | 0.07 g | TOPICAL | unapproved drug other | 9 sections |
BABYSONS | HUMAN OTC DRUG LABEL | 1 | 73519-001 | OINTMENT | 50 mg | TOPICAL | OTC monograph not final | 11 sections |
Yakkongmo scalp deep cleansingshampoo | HUMAN OTC DRUG LABEL | 4 | 73540-001 | SHAMPOO | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
Yakkongmo hair serum tonic | HUMAN OTC DRUG LABEL | 3 | 73540-002 | LIQUID | 0.20 g | TOPICAL | unapproved drug other | 7 sections |
Yakkongmo treatment | HUMAN OTC DRUG LABEL | 3 | 73540-003 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |